Blood centres across India that fail mandatory quality audits could soon be barred from carrying out routine testing until they identify the cause of the failure and resolve it, according to proposals submitted to the country's top drug-regulatory advisory body.
The proposal, submitted to the apex advisory body, is aimed at tightening quality oversight of blood centres, which handle routine testing as part of their operations. Under the plan, centres that do not clear the mandatory audits would not be permitted to continue routine testing until they pinpoint what went wrong and fix the problem.
The move, as described in the proposals, would make the findings of mandatory quality audits a condition for continuing routine testing at blood centres. It is not yet clear when the proposal will be taken up or whether it has been approved.
The details were reported from New Delhi. No further information was immediately available on the scope of the proposed curbs or the timeline for their implementation.
